{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T23:03:30Z","timestamp":1784070210175,"version":"3.55.0"},"reference-count":123,"publisher":"Elsevier BV","issue":"15","license":[{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,7,31]],"date-time":"2024-07-31T00:00:00Z","timestamp":1722384000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100008108","name":"Taipei Tzu Chi Hospital","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008108","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005925","name":"Buddhist Tzu Chi Medical Foundation","doi-asserted-by":"publisher","award":["2\/3"],"award-info":[{"award-number":["2\/3"]}],"id":[{"id":"10.13039\/501100005925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005925","name":"Buddhist Tzu Chi Medical Foundation","doi-asserted-by":"publisher","award":["3\/3"],"award-info":[{"award-number":["3\/3"]}],"id":[{"id":"10.13039\/501100005925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005925","name":"Buddhist Tzu Chi Medical Foundation","doi-asserted-by":"publisher","award":["TCRD-TPE-111-01"],"award-info":[{"award-number":["TCRD-TPE-111-01"]}],"id":[{"id":"10.13039\/501100005925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005925","name":"Buddhist Tzu Chi Medical Foundation","doi-asserted-by":"publisher","award":["TCRD-TPE-110-02"],"award-info":[{"award-number":["TCRD-TPE-110-02"]}],"id":[{"id":"10.13039\/501100005925","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heliyon"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1016\/j.heliyon.2024.e35590","type":"journal-article","created":{"date-parts":[[2024,8,2]],"date-time":"2024-08-02T07:23:16Z","timestamp":1722583396000},"page":"e35590","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Role of TGF\u03b2-producing regulatory T cells in scleroderma and end-stage organ failure"],"prefix":"10.1016","volume":"10","author":[{"given":"Kuo-Cheng","family":"Lu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kuo-Wang","family":"Tsai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1360-1422","authenticated-orcid":false,"given":"Wan-Chung","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.heliyon.2024.e35590_bib1","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines11092384","article-title":"Interplay of chemokines receptors, toll-like receptors, and host immunological pathways","volume":"11","author":"Chu","year":"2023","journal-title":"Biomedicines"},{"key":"10.1016\/j.heliyon.2024.e35590_bib2","doi-asserted-by":"crossref","first-page":"1992","DOI":"10.3389\/fimmu.2020.01992","article-title":"A framework of all discovered immunological pathways and their roles for four specific types of pathogens and hypersensitivities","volume":"11","author":"Hu","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.heliyon.2024.e35590_bib3","doi-asserted-by":"crossref","DOI":"10.3390\/ijms222413310","article-title":"The framework for human host immune responses to four types of parasitic infections and relevant key JAK\/STAT signaling","volume":"22","author":"Wen","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.heliyon.2024.e35590_bib4","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines10102497","article-title":"Cancer as a dysfunctional immune disorder: pro-tumor TH1-like immune response and anti-tumor THalphabeta immune response based on the complete updated framework of host immunological pathways","volume":"10","author":"Lee","year":"2022","journal-title":"Biomedicines"},{"key":"10.1016\/j.heliyon.2024.e35590_bib5","doi-asserted-by":"crossref","DOI":"10.3390\/v14020408","article-title":"THalphabeta immunological pathway as protective immune response against prion diseases: an insight for prion infection therapy","volume":"14","author":"Tsou","year":"2022","journal-title":"Viruses"},{"key":"10.1016\/j.heliyon.2024.e35590_bib6","article-title":"The central THalphabeta immunity associated cytokine: IL-10 has a strong anti-tumor ability toward established cancer models in vivo and toward cancer cells in vitro","volume":"11","author":"Hu","year":"2021","journal-title":"Front. Oncol."},{"key":"10.1016\/j.heliyon.2024.e35590_bib7","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1186\/1475-2875-12-392","article-title":"Human immune responses to Plasmodium falciparum infection: molecular evidence for a suboptimal TH\u03b1\u03b2 and TH17 bias over ideal and effective traditional TH1 immune response","volume":"12","author":"Hu","year":"2013","journal-title":"Malar. J."},{"key":"10.1016\/j.heliyon.2024.e35590_bib8","doi-asserted-by":"crossref","first-page":"8180","DOI":"10.4049\/jimmunol.179.12.8180","article-title":"Cytokine-mediated regulation of human B cell differentiation into Ig-secreting cells: predominant role of IL-21 produced by CXCR5+ T follicular helper cells","volume":"179","author":"Bryant","year":"2007","journal-title":"J. Immunol."},{"key":"10.1016\/j.heliyon.2024.e35590_bib9","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1038\/ni.1690","article-title":"The costimulatory molecule ICOS regulates the expression of c-Maf and IL-21 in the development of follicular T helper cells and TH-17 cells","volume":"10","author":"Bauquet","year":"2009","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.heliyon.2024.e35590_bib10","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1084\/jem.20091738","article-title":"IL-21 acts directly on B cells to regulate Bcl-6 expression and germinal center responses","volume":"207","author":"Linterman","year":"2010","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.heliyon.2024.e35590_bib11","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1158\/0008-5472.CAN-09-2314","article-title":"Prolactin inhibits BCL6 expression in breast cancer through a Stat5a-dependent mechanism","volume":"70","author":"Tran","year":"2010","journal-title":"Cancer Res."},{"key":"10.1016\/j.heliyon.2024.e35590_bib12","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.immuni.2008.05.009","article-title":"Generation of T follicular helper cells is mediated by interleukin-21 but independent of T helper 1, 2, or 17 cell lineages","volume":"29","author":"Nurieva","year":"2008","journal-title":"Immunity"},{"key":"10.1016\/j.heliyon.2024.e35590_bib13","doi-asserted-by":"crossref","first-page":"2348","DOI":"10.4049\/jimmunol.136.7.2348","article-title":"Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins","volume":"136","author":"Mosmann","year":"1986","journal-title":"J. Immunol."},{"key":"10.1016\/j.heliyon.2024.e35590_bib14","doi-asserted-by":"crossref","first-page":"F31","DOI":"10.1084\/jem.192.11.F31","article-title":"Follicular homing T helper (Th) cells and the Th1\/Th2 paradigm","volume":"192","author":"Mackay","year":"2000","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.heliyon.2024.e35590_bib15","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1038\/nm.2628","article-title":"An essential role for TH2-type responses in limiting acute tissue damage during experimental helminth infection","volume":"18","author":"Chen","year":"2012","journal-title":"Nat. Med."},{"key":"10.1016\/j.heliyon.2024.e35590_bib16","doi-asserted-by":"crossref","first-page":"3779","DOI":"10.4049\/jimmunol.1303076","article-title":"STAT3 activation in Th17 and Th22 cells controls IL-22-mediated epithelial host defense during infectious colitis","volume":"193","author":"Backert","year":"2014","journal-title":"J. Immunol."},{"key":"10.1016\/j.heliyon.2024.e35590_bib17","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1016\/j.immuni.2012.08.024","article-title":"Th22 cells are an important source of IL-22 for host protection against enteropathogenic bacteria","volume":"37","author":"Basu","year":"2012","journal-title":"Immunity"},{"key":"10.1016\/j.heliyon.2024.e35590_bib18","first-page":"3573","article-title":"Th22 cells represent a distinct human T cell subset involved in epidermal immunity and remodeling","volume":"119","author":"Eyerich","year":"2009","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.heliyon.2024.e35590_bib19","doi-asserted-by":"crossref","first-page":"5531","DOI":"10.4049\/jimmunol.0904091","article-title":"IL-22 induces an acute-phase response","volume":"185","author":"Liang","year":"2010","journal-title":"J. Immunol."},{"key":"10.1016\/j.heliyon.2024.e35590_bib20","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1089\/jir.2013.0099","article-title":"Interleukin-22 aggravates murine acute graft-versus-host disease by expanding effector T cell and reducing regulatory T cell","volume":"34","author":"Zhao","year":"2014","journal-title":"J. Interferon Cytokine Res. : the official journal of the International Society for Interferon and Cytokine Research"},{"key":"10.1016\/j.heliyon.2024.e35590_bib21","doi-asserted-by":"crossref","first-page":"S16","DOI":"10.1097\/01.TP.0000106468.96542.26","article-title":"The role of cytokines (and not only) in inducing and expanding T regulatory type 1 cells","volume":"77","author":"Battaglia","year":"2004","journal-title":"Transplantation"},{"key":"10.1016\/j.heliyon.2024.e35590_bib22","doi-asserted-by":"crossref","first-page":"5530","DOI":"10.4049\/jimmunol.166.9.5530","article-title":"de Waal Malefyt, R.; Roncarolo, M.G. IFN-alpha and IL-10 induce the differentiation of human type 1 T regulatory cells","volume":"166","author":"Levings","year":"2001","journal-title":"J. Immunol."},{"key":"10.1016\/j.heliyon.2024.e35590_bib23","doi-asserted-by":"crossref","DOI":"10.3390\/v14020408","article-title":"TH\u03b1\u03b2 immunological pathway as protective immune response against prion diseases: an insight for prion infection therapy","volume":"14","author":"Tsou","year":"2022","journal-title":"Viruses"},{"key":"10.1016\/j.heliyon.2024.e35590_bib24","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1084\/jem.20111174","article-title":"STAT5 is a potent negative regulator of TFH cell differentiation","volume":"209","author":"Johnston","year":"2012","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.heliyon.2024.e35590_bib25","doi-asserted-by":"crossref","first-page":"4368","DOI":"10.1182\/blood-2006-11-055756","article-title":"Nonredundant roles for Stat5a\/b in directly regulating Foxp3","volume":"109","author":"Yao","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.heliyon.2024.e35590_bib26","first-page":"327","article-title":"Distribution of IgA 1 and IgA 2 plasma cells in various normal human tissues and in the jejunum of plasma IgA-deficient patients","volume":"33","author":"Andre","year":"1978","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.heliyon.2024.e35590_bib27","doi-asserted-by":"crossref","first-page":"5217","DOI":"10.4049\/jimmunol.161.10.5217","article-title":"CD40 engagement triggers switching to IgA1 and IgA2 in human B cells through induction of endogenous TGF-beta: evidence for TGF-beta but not IL-10-dependent direct S mu-->S alpha and sequential S mu-->S gamma, S gamma-->S alpha DNA recombination","volume":"161","author":"Zan","year":"1998","journal-title":"J. Immunol."},{"key":"10.1016\/j.heliyon.2024.e35590_bib28","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.01992","article-title":"A framework of all discovered immunological pathways and their roles for four specific types of pathogens and hypersensitivities","volume":"11","author":"Hu","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.heliyon.2024.e35590_bib29","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.imbio.2011.07.032","article-title":"IL-12 inhibits the TGF-beta-dependent T cell developmental programs and skews the TGF-beta-induced differentiation into a Th1-like direction","volume":"217","author":"Prochazkova","year":"2012","journal-title":"Immunobiology"},{"key":"10.1016\/j.heliyon.2024.e35590_bib30","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1002\/eji.201040724","article-title":"Generation of human Th1-like regulatory CD4+ T cells by an intrinsic IFN-gamma- and T-bet-dependent pathway","volume":"41","author":"Zheng","year":"2011","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.heliyon.2024.e35590_bib31","doi-asserted-by":"crossref","first-page":"3113","DOI":"10.4049\/jimmunol.1003189","article-title":"A novel human IgA monoclonal antibody protects against tuberculosis","volume":"186","author":"Balu","year":"2011","journal-title":"J. Immunol."},{"key":"10.1016\/j.heliyon.2024.e35590_bib32","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1001246","article-title":"Critical role of IRF-5 in the development of T helper 1 responses to Leishmania donovani infection","volume":"7","author":"Paun","year":"2011","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.heliyon.2024.e35590_bib33","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1111\/cei.13009","article-title":"Interleukin-9 over-expression and T helper 9 polarization in systemic sclerosis patients","volume":"190","author":"Guggino","year":"2017","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.heliyon.2024.e35590_bib34","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1038\/ni.2920","article-title":"TH9 cells that express the transcription factor PU.1 drive T cell\u2013mediated colitis via IL-9 receptor signaling in intestinal epithelial cells","volume":"15","author":"Gerlach","year":"2014","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.heliyon.2024.e35590_bib35","doi-asserted-by":"crossref","first-page":"2466","DOI":"10.4049\/jimmunol.1300911","article-title":"IL-4-, TGF-\u03b2-, and IL-1-dependent expansion of parasite antigen-specific Th9 cells is associated with clinical pathology in human lymphatic filariasis","volume":"191","author":"Anuradha","year":"2013","journal-title":"J. Immunol."},{"key":"10.1016\/j.heliyon.2024.e35590_bib36","doi-asserted-by":"crossref","first-page":"3508","DOI":"10.1073\/pnas.1301138111","article-title":"Opposing actions of IL-2 and IL-21 on Th9 differentiation correlate with their differential regulation of BCL6 expression","volume":"111","author":"Liao","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.heliyon.2024.e35590_bib37","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1038\/s12276-021-00632-9","article-title":"A critical role for Th17 cell-derived TGF-beta1 in regulating the stability and pathogenicity of autoimmune Th17 cells","volume":"53","author":"Choi","year":"2021","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.heliyon.2024.e35590_bib38","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.cell.2015.08.058","article-title":"Th17 cell induction by adhesion of microbes to intestinal epithelial cells","volume":"163","author":"Atarashi","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.heliyon.2024.e35590_bib39","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1016\/j.immuni.2009.02.007","article-title":"Critical regulation of early Th17 cell differentiation by interleukin-1 signaling","volume":"30","author":"Chung","year":"2009","journal-title":"Immunity"},{"key":"10.1016\/j.heliyon.2024.e35590_bib40","doi-asserted-by":"crossref","first-page":"4240","DOI":"10.1182\/blood-2008-10-183251","article-title":"IL-17-producing human peripheral regulatory T cells retain suppressive function","volume":"113","author":"Beriou","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.heliyon.2024.e35590_bib41","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1038\/cmi.2012.10","article-title":"Regulation of TH17 cell differentiation by innate immune signals","volume":"9","author":"Huang","year":"2012","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.heliyon.2024.e35590_bib42","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1038\/ni.1952","article-title":"IL-35-mediated induction of a potent regulatory T cell population","volume":"11","author":"Collison","year":"2010","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.heliyon.2024.e35590_bib43","doi-asserted-by":"crossref","first-page":"3439","DOI":"10.1093\/rheumatology\/kead053","article-title":"The role of iTr35 cells in the inflammatory response and fibrosis progression of systemic sclerosis","volume":"62","author":"Yang","year":"2023","journal-title":"Rheumatology"},{"key":"10.1016\/j.heliyon.2024.e35590_bib44","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.clim.2011.06.007","article-title":"Th3 immune responses in the progression of leprosy via molecular cross-talks of TGF-beta, CTLA-4 and Cbl-b","volume":"141","author":"Kumar","year":"2011","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.heliyon.2024.e35590_bib45","first-page":"422","article-title":"T helper cells in patients with chronic hepatitis B virus infection","volume":"115","author":"Jiang","year":"2002","journal-title":"Chin. Med. J."},{"key":"10.1016\/j.heliyon.2024.e35590_bib46","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1016\/j.celrep.2014.04.049","article-title":"The CD3 conformational change in the gammadelta T cell receptor is not triggered by antigens but can be enforced to enhance tumor killing","volume":"7","author":"Dopfer","year":"2014","journal-title":"Cell Rep."},{"key":"10.1016\/j.heliyon.2024.e35590_bib47","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1093\/emboj\/16.6.1360","article-title":"CD3 delta deficiency arrests development of the alpha beta but not the gamma delta T cell lineage","volume":"16","author":"Dave","year":"1997","journal-title":"EMBO J."},{"key":"10.1016\/j.heliyon.2024.e35590_bib48","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1111\/imr.12918","article-title":"From thymus to periphery: molecular basis of effector gammadelta-T cell differentiation","volume":"298","author":"Fiala","year":"2020","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.heliyon.2024.e35590_bib49","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1093\/intimm\/11.12.1907","article-title":"Gammadelta T cells regulate mucosally induced tolerance in a dose-dependent fashion","volume":"11","author":"Fujihashi","year":"1999","journal-title":"Int. Immunol."},{"key":"10.1016\/j.heliyon.2024.e35590_bib50","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1046\/j.1523-1747.2002.01830.x","article-title":"GammadeltaT cells regulate the development of hapten-specific CD8+ effector T cells in contact hypersensitivity responses","volume":"119","author":"Guan","year":"2002","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.heliyon.2024.e35590_bib51","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1084\/jem.20080611","article-title":"Functional anergy in a subpopulation of naive B cells from healthy humans that express autoreactive immunoglobulin receptors","volume":"206","author":"Duty","year":"2009","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.heliyon.2024.e35590_bib52","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1073\/pnas.90.5.1887","article-title":"Immunoglobulin D-deficient mice can mount normal immune responses to thymus-independent and -dependent antigens","volume":"90","author":"Nitschke","year":"1993","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.heliyon.2024.e35590_bib53","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1038\/342385a0","article-title":"Induction of self-tolerance in mature peripheral B lymphocytes","volume":"342","author":"Goodnow","year":"1989","journal-title":"Nature"},{"key":"10.1016\/j.heliyon.2024.e35590_bib54","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1002\/eji.1830230243","article-title":"Cross-linking of surface IgM, but not surface IgD receptors, by soluble monoclonal antibodies primes murine B cells to secrete immunoglobulin in response to lymphokines","volume":"23","author":"Phillips","year":"1993","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.heliyon.2024.e35590_bib55","doi-asserted-by":"crossref","first-page":"4640","DOI":"10.4049\/jimmunol.1001946","article-title":"Anergic responses characterize a large fraction of human autoreactive naive B cells expressing low levels of surface IgM","volume":"186","author":"Quach","year":"2011","journal-title":"J. Immunol."},{"key":"10.1016\/j.heliyon.2024.e35590_bib56","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1097\/BOR.0b013e32833038ce","article-title":"Noncanonical transforming growth factor beta signaling in scleroderma fibrosis","volume":"21","author":"Trojanowska","year":"2009","journal-title":"Curr. Opin. Rheumatol."},{"key":"10.1016\/j.heliyon.2024.e35590_bib57","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.900638","article-title":"The pathophysiological roles of regulatory T cells in the early phase of systemic sclerosis","volume":"13","author":"Kobayashi","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.heliyon.2024.e35590_bib58","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20190103","article-title":"Transforming growth factor-beta in tissue fibrosis","volume":"217","author":"Frangogiannis","year":"2020","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.heliyon.2024.e35590_bib59","doi-asserted-by":"crossref","first-page":"3","DOI":"10.7555\/JBR.31.20170034","article-title":"Transforming growth factor-beta signaling in systemic sclerosis","volume":"32","author":"Ayers","year":"2018","journal-title":"J Biomed Res"},{"key":"10.1016\/j.heliyon.2024.e35590_bib60","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1046\/j.1523-1747.1998.00073.x","article-title":"Increased expression of TGF-beta receptors by scleroderma fibroblasts: evidence for contribution of autocrine TGF-beta signaling to scleroderma phenotype","volume":"110","author":"Kawakami","year":"1998","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.heliyon.2024.e35590_bib61","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1186\/ar1976","article-title":"Scar wars: is TGFbeta the phantom menace in scleroderma?","volume":"8","author":"Leask","year":"2006","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.heliyon.2024.e35590_bib62","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1038\/nrrheum.2014.137","article-title":"Transforming growth factor beta\u2013at the centre of systemic sclerosis","volume":"10","author":"Lafyatis","year":"2014","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.heliyon.2024.e35590_bib63","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1038\/labinvest.2017.20","article-title":"Increased expression of latent TGF-beta-binding protein 4 affects the fibrotic process in scleroderma by TGF-beta\/SMAD signaling","volume":"97","author":"Lu","year":"2017","journal-title":"Lab. Invest."},{"key":"10.1016\/j.heliyon.2024.e35590_bib64","doi-asserted-by":"crossref","first-page":"5693","DOI":"10.4049\/jimmunol.163.10.5693","article-title":"Anti-TGF-\u03b2 treatment prevents skin and lung fibrosis in murine sclerodermatous graft-versus-host disease: a model for human scleroderma","volume":"163","author":"McCormick","year":"1999","journal-title":"J. Immunol."},{"key":"10.1016\/j.heliyon.2024.e35590_bib65","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.imlet.2013.05.006","article-title":"Genetic polymorphisms of FOXP3 in Italian patients with systemic sclerosis","volume":"152","author":"D'Amico","year":"2013","journal-title":"Immunol. Lett."},{"key":"10.1016\/j.heliyon.2024.e35590_bib66","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1002\/art.1780330515","article-title":"The IgG, IgM, and IgA isotypes of anti-topoisomerase I and anticentromere autoantibodies","volume":"33","author":"Hildebrandt","year":"1990","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.heliyon.2024.e35590_bib67","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1007\/s00296-018-4071-8","article-title":"Higher levels of serum interleukin-35 are associated with the severity of pulmonary fibrosis and Th2 responses in patients with systemic sclerosis","volume":"38","author":"Tang","year":"2018","journal-title":"Rheumatol. Int."},{"key":"10.1016\/j.heliyon.2024.e35590_bib68","doi-asserted-by":"crossref","first-page":"446","DOI":"10.7326\/0003-4819-110-6-446","article-title":"Interleukin-2 in scleroderma: correlation of serum level with extent of skin involvement and disease duration","volume":"110","author":"Kahaleh","year":"1989","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.heliyon.2024.e35590_bib69","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1161\/CIRCULATIONAHA.118.036065","article-title":"Dysfunctional and proinflammatory regulatory T-lymphocytes are essential for adverse cardiac remodeling in ischemic cardiomyopathy","volume":"139","author":"Bansal","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.heliyon.2024.e35590_bib70","doi-asserted-by":"crossref","first-page":"e30","DOI":"10.1111\/j.1755-5922.2010.00228.x","article-title":"Targeting fibrosis for the treatment of heart failure: a role for transforming growth factor-beta","volume":"30","author":"Edgley","year":"2012","journal-title":"Cardiovasc Ther"},{"key":"10.1016\/j.heliyon.2024.e35590_bib71","doi-asserted-by":"crossref","first-page":"2301","DOI":"10.1172\/JCI44824","article-title":"Pivotal role of cardiomyocyte TGF-beta signaling in the murine pathological response to sustained pressure overload","volume":"121","author":"Koitabashi","year":"2011","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.heliyon.2024.e35590_bib72","doi-asserted-by":"crossref","first-page":"2584","DOI":"10.1007\/s00018-006-6085-8","article-title":"Role of transforming growth factor-beta in the progression of heart failure","volume":"63","author":"Lim","year":"2006","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.heliyon.2024.e35590_bib73","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1016\/S1053-2498(01)00296-0","article-title":"TGF-beta1 gene polymorphisms in patients with end-stage heart failure","volume":"20","author":"Holweg","year":"2001","journal-title":"J. Heart Lung Transplant."},{"key":"10.1016\/j.heliyon.2024.e35590_bib74","doi-asserted-by":"crossref","DOI":"10.1172\/JCI146926","article-title":"Smad7 effects on TGF-beta and ErbB2 restrain myofibroblast activation and protect from postinfarction heart failure","volume":"132","author":"Humeres","year":"2022","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.heliyon.2024.e35590_bib75","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1186\/s12964-020-00555-4","article-title":"TGF-beta and WNT signaling pathways in cardiac fibrosis: non-coding RNAs come into focus","volume":"18","author":"Yousefi","year":"2020","journal-title":"Cell Commun. Signal."},{"key":"10.1016\/j.heliyon.2024.e35590_bib76","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.yjmcc.2018.08.005","article-title":"Interleukin-17 enhances cardiac ventricular remodeling via activating MAPK pathway in ischemic heart failure","volume":"122","author":"Chang","year":"2018","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.heliyon.2024.e35590_bib77","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/1479-5876-9-28","article-title":"Increase of plasma IL-9 and decrease of plasma IL-5, IL-7, and IFN-gamma in patients with chronic heart failure","volume":"9","author":"Cappuzzello","year":"2011","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.heliyon.2024.e35590_bib78","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24097717","article-title":"Role of coxsackievirus B3-induced immune responses in the transition from myocarditis to dilated cardiomyopathy and heart failure","volume":"24","author":"Yip","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.heliyon.2024.e35590_bib79","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0007602","article-title":"TGF-beta inhibitor therapy decreases fibrosis and stimulates cardiac improvement in a pre-clinical study of chronic Chagas' heart disease","volume":"13","author":"Ferreira","year":"2019","journal-title":"PLoS Neglected Trop. Dis."},{"key":"10.1016\/j.heliyon.2024.e35590_bib80","article-title":"FOXP3+ regulatory T cells in hepatic fibrosis and splenomegaly caused by schistosoma japonicum: the spleen may Be a major source of Tregs in subjects with splenomegaly","volume":"10","author":"Romano","year":"2016","journal-title":"PLoS Neglected Trop. Dis."},{"key":"10.1016\/j.heliyon.2024.e35590_bib81","first-page":"2963","article-title":"Changes of Th17\/Treg ratio in the transition of chronic hepatitis B to liver cirrhosis and correlations with liver function and inflammation","volume":"17","author":"Mou","year":"2019","journal-title":"Exp. Ther. Med."},{"key":"10.1016\/j.heliyon.2024.e35590_bib82","doi-asserted-by":"crossref","first-page":"3614","DOI":"10.1007\/s10620-020-06077-w","article-title":"Interleukin-35 suppresses CD8(+) T cell activity in patients with viral hepatitis-induced acute-on-chronic liver failure","volume":"65","author":"Yang","year":"2020","journal-title":"Dig. Dis. Sci."},{"key":"10.1016\/j.heliyon.2024.e35590_bib83","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1111\/imm.13111","article-title":"Interleukin-9 blockage reduces early hepatic granuloma formation and fibrosis during Schistosoma japonicum infection in mice","volume":"158","author":"Zhan","year":"2019","journal-title":"Immunology"},{"key":"10.1016\/j.heliyon.2024.e35590_bib84","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1136\/jcp.2006.044776","article-title":"Naturally-occurring regulatory T cells are increased in inflamed portal tracts with cholangiopathy in primary biliary cirrhosis","volume":"60","author":"Sasaki","year":"2007","journal-title":"J. Clin. Pathol."},{"key":"10.1016\/j.heliyon.2024.e35590_bib85","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1007\/s10238-015-0381-2","article-title":"Elevated circulating CD14(low)CD16(+) monocyte subset in primary biliary cirrhosis correlates with liver injury and promotes Th1 polarization","volume":"16","author":"Peng","year":"2016","journal-title":"Clin. Exp. Med."},{"key":"10.1016\/j.heliyon.2024.e35590_bib86","doi-asserted-by":"crossref","first-page":"735","DOI":"10.3899\/jrheum.200293","article-title":"IgA vasculitis with underlying liver cirrhosis: a French nationwide case series of 20 patients","volume":"48","author":"Elhani","year":"2021","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.heliyon.2024.e35590_bib87","doi-asserted-by":"crossref","first-page":"5783","DOI":"10.3748\/wjg.v13.i43.5783","article-title":"Association of liver cirrhosis related IgA nephropathy with portal hypertension","volume":"13","author":"Kalambokis","year":"2007","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.heliyon.2024.e35590_bib88","doi-asserted-by":"crossref","first-page":"2264","DOI":"10.1038\/s41598-019-38811-4","article-title":"Interleukin 17A promotes diabetic kidney injury","volume":"9","author":"Ma","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.heliyon.2024.e35590_bib89","doi-asserted-by":"crossref","first-page":"2102","DOI":"10.2337\/db10-1344","article-title":"Anti-islet autoantibodies trigger autoimmune diabetes in the presence of an increased frequency of islet-reactive CD4 T cells","volume":"60","author":"Silva","year":"2011","journal-title":"Diabetes"},{"key":"10.1016\/j.heliyon.2024.e35590_bib90","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1093\/cvr\/cvx177","article-title":"Interleukin-9 mediates chronic kidney disease-dependent vein graft disease: a role for mast cells","volume":"113","author":"Zhang","year":"2017","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.heliyon.2024.e35590_bib91","doi-asserted-by":"crossref","first-page":"e9895","DOI":"10.1097\/MD.0000000000009895","article-title":"Haemolytic-uremic syndrome due to infection with adenovirus: a case report and literature review","volume":"97","author":"Birlutiu","year":"2018","journal-title":"Medicine (Baltim.)"},{"key":"10.1016\/j.heliyon.2024.e35590_bib92","first-page":"341","article-title":"A case of atypical hemolytic uremic syndrome","volume":"8","author":"Fallahzadeh","year":"2014","journal-title":"Iran J Kidney Dis"},{"key":"10.1016\/j.heliyon.2024.e35590_bib93","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijmm.2024.151598","article-title":"Different populations of A(H1N1)pdm09 viruses in a patient with hemolytic-uremic syndrome","volume":"314","author":"Fu","year":"2024","journal-title":"Int J Med Microbiol"},{"key":"10.1016\/j.heliyon.2024.e35590_bib94","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1159\/000477132","article-title":"Serum matrix metalloproteinase-7 level is associated with fibrosis and renal survival in patients with IgA nephropathy","volume":"42","author":"Zhang","year":"2017","journal-title":"Kidney Blood Press. Res."},{"key":"10.1016\/j.heliyon.2024.e35590_bib95","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1007\/s12519-009-0040-3","article-title":"Expression and significance of TGF-beta1\/Smad signaling pathway in children with IgA nephropathy","volume":"5","author":"Wu","year":"2009","journal-title":"World J Pediatr"},{"key":"10.1016\/j.heliyon.2024.e35590_bib96","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1038\/ki.2009.130","article-title":"Circulating TGF-beta1 as a reliable biomarker for chronic kidney disease progression in the African-American population","volume":"76","author":"Lee","year":"2009","journal-title":"Kidney Int."},{"key":"10.1016\/j.heliyon.2024.e35590_bib97","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1038\/ki.1995.443","article-title":"PDGF and TGF-beta contribute to the natural course of human IgA glomerulonephritis","volume":"48","author":"Niemir","year":"1995","journal-title":"Kidney Int."},{"key":"10.1016\/j.heliyon.2024.e35590_bib98","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1046\/j.1523-1755.1998.00127.x","article-title":"Evidence that TGF-beta should be a therapeutic target in diabetic nephropathy","volume":"54","author":"Border","year":"1998","journal-title":"Kidney Int."},{"key":"10.1016\/j.heliyon.2024.e35590_bib99","doi-asserted-by":"crossref","first-page":"187","DOI":"10.3389\/fcell.2020.00187","article-title":"Transforming growth factor-beta1 in diabetic kidney disease","volume":"8","author":"Zhao","year":"2020","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.heliyon.2024.e35590_bib100","article-title":"Hydroxysafflor yellow A ameliorates renal fibrosis by suppressing TGF-beta1-induced epithelial-to-mesenchymal transition","volume":"11","author":"Hu","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.heliyon.2024.e35590_bib101","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1161\/CIRCRESAHA.123.322494","article-title":"LTBP4 protects against renal fibrosis via mitochondrial and vascular impacts","volume":"133","author":"Su","year":"2023","journal-title":"Circ. Res."},{"key":"10.1016\/j.heliyon.2024.e35590_bib102","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/j.omtn.2022.04.002","article-title":"MicroRNA-10a\/b inhibit TGF-beta\/Smad-induced renal fibrosis by targeting TGF-beta receptor 1 in diabetic kidney disease","volume":"28","author":"Li","year":"2022","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.heliyon.2024.e35590_bib103","first-page":"1965","article-title":"RACK1 silencing attenuates renal fibrosis by inhibiting TGF-beta signaling","volume":"40","author":"Feng","year":"2017","journal-title":"Int. J. Mol. Med."},{"key":"10.1016\/j.heliyon.2024.e35590_bib104","doi-asserted-by":"crossref","first-page":"e9206","DOI":"10.1590\/1414-431x20209206","article-title":"MicroRNA-302b mitigates renal fibrosis via inhibiting TGF-beta\/Smad pathway activation","volume":"54","author":"Sun","year":"2021","journal-title":"Braz. J. Med. Biol. Res."},{"key":"10.1016\/j.heliyon.2024.e35590_bib105","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1513\/pats.201203-023AW","article-title":"The impact of TGF-beta on lung fibrosis: from targeting to biomarkers","volume":"9","author":"Fernandez","year":"2012","journal-title":"Proc. Am. Thorac. Soc."},{"key":"10.1016\/j.heliyon.2024.e35590_bib106","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1186\/s12931-020-1319-0","article-title":"TGF-beta pathway activation by idiopathic pulmonary fibrosis (IPF) fibroblast derived soluble factors is mediated by IL-6 trans-signaling","volume":"21","author":"Epstein Shochet","year":"2020","journal-title":"Respir. Res."},{"key":"10.1016\/j.heliyon.2024.e35590_bib107","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1186\/s12931-017-0653-3","article-title":"Increased activated regulatory T cells proportion correlate with the severity of idiopathic pulmonary fibrosis","volume":"18","author":"Hou","year":"2017","journal-title":"Respir. Res."},{"key":"10.1016\/j.heliyon.2024.e35590_bib108","doi-asserted-by":"crossref","DOI":"10.2174\/157340810791233033","article-title":"TGF-Beta: titan of lung fibrogenesis","volume":"6","author":"Yue","year":"2010","journal-title":"Curr. Enzym. Inhib."},{"key":"10.1016\/j.heliyon.2024.e35590_bib109","doi-asserted-by":"crossref","DOI":"10.1080\/21505594.2023.2190650","article-title":"An important call: suggestion of using IL-10 as therapeutic agent for COVID-19 with ARDS and other complications","volume":"14","author":"Shih","year":"2023","journal-title":"Virulence"},{"key":"10.1016\/j.heliyon.2024.e35590_bib110","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1038\/s41420-021-00429-9","article-title":"Plasma IL-6 levels following corticosteroid therapy as an indicator of ICU length of stay in critically ill COVID-19 patients","volume":"7","author":"Awasthi","year":"2021","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.heliyon.2024.e35590_bib111","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1089\/vim.2011.0099","article-title":"SARS-CoV regulates immune function-related gene expression in human monocytic cells","volume":"25","author":"Hu","year":"2012","journal-title":"Viral Immunol."},{"key":"10.1016\/j.heliyon.2024.e35590_bib112","doi-asserted-by":"crossref","DOI":"10.1080\/21505594.2023.2190650","article-title":"An important call: suggestion of using IL-10 as therapeutic agent for COVID-19 with ARDS and other complications","volume":"14","author":"Shih","year":"2023","journal-title":"Virulence"},{"key":"10.1016\/j.heliyon.2024.e35590_bib113","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1016\/j.jaci.2012.09.027","article-title":"Programmed cell death ligand 2 regulates TH9 differentiation and induction of chronic airway hyperreactivity","volume":"131","author":"Kerzerho","year":"2013","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.heliyon.2024.e35590_bib114","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1165\/rcmb.2006-0397OC","article-title":"Profibrotic effect of IL-9 overexpression in a model of airway remodeling","volume":"37","author":"van den Br\u00fble","year":"2007","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"10.1016\/j.heliyon.2024.e35590_bib115","doi-asserted-by":"crossref","DOI":"10.3390\/cells10113209","article-title":"Deleterious role of Th9 cells in pulmonary fibrosis","volume":"10","author":"Deng","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.heliyon.2024.e35590_bib116","first-page":"26","article-title":"Correlation between the kinetics of Th1, Th2 cells and pathology in a murine model of experimental pulmonary tuberculosis","volume":"89","author":"Hern\u00e1ndez-Pando","year":"1996","journal-title":"Immunology"},{"key":"10.1016\/j.heliyon.2024.e35590_bib117","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2021.704222","article-title":"The role of herpes viruses in pulmonary fibrosis","volume":"8","author":"Duckworth","year":"2021","journal-title":"Front. Med."},{"key":"10.1016\/j.heliyon.2024.e35590_bib118","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1016\/j.chest.2019.10.032","article-title":"Viral infection increases the risk of idiopathic pulmonary fibrosis: a meta-analysis","volume":"157","author":"Sheng","year":"2020","journal-title":"Chest"},{"key":"10.1016\/j.heliyon.2024.e35590_bib119","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1038\/s41419-019-1873-x","article-title":"Transforming growth factor (TGF)-beta1-induced miR-133a inhibits myofibroblast differentiation and pulmonary fibrosis","volume":"10","author":"Wei","year":"2019","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.heliyon.2024.e35590_bib120","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1177\/0960327119895549","article-title":"Inhibition of miR-182-5p attenuates pulmonary fibrosis via TGF-beta\/Smad pathway","volume":"39","author":"Chen","year":"2020","journal-title":"Hum. Exp. Toxicol."},{"key":"10.1016\/j.heliyon.2024.e35590_bib121","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000492791","article-title":"Hepatorenal syndrome or hepatocardiorenal syndrome: revisiting basic concepts in view of emerging data","volume":"9","author":"Kazory","year":"2019","journal-title":"Cardiorenal Med."},{"key":"10.1016\/j.heliyon.2024.e35590_bib122","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines11041029","article-title":"Differences in the profile of circulating immune cell subsets in males with type 2 cardiorenal syndrome versus CKD patients without established cardiovascular disease","volume":"11","author":"Duni","year":"2023","journal-title":"Biomedicines"},{"key":"10.1016\/j.heliyon.2024.e35590_bib123","doi-asserted-by":"crossref","first-page":"2433","DOI":"10.1016\/j.jacc.2015.04.024","article-title":"Cardio-pulmonary-renal interactions: a multidisciplinary approach","volume":"65","author":"Husain-Syed","year":"2015","journal-title":"J. Am. Coll. Cardiol."}],"container-title":["Heliyon"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844024116210?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844024116210?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T22:03:47Z","timestamp":1784066627000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405844024116210"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8]]},"references-count":123,"journal-issue":{"issue":"15","published-print":{"date-parts":[[2024,8]]}},"alternative-id":["S2405844024116210"],"URL":"https:\/\/doi.org\/10.1016\/j.heliyon.2024.e35590","relation":{},"ISSN":["2405-8440"],"issn-type":[{"value":"2405-8440","type":"print"}],"subject":[],"published":{"date-parts":[[2024,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Role of TGF\u03b2-producing regulatory T cells in scleroderma and end-stage organ failure","name":"articletitle","label":"Article Title"},{"value":"Heliyon","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.heliyon.2024.e35590","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"e35590"}}